HJ SCIENCE-B (06132) has released its interim results for the six months ended June 30, 2026, revealing a net loss attributable to shareholders that deepened significantly.

The company generated revenue of RMB 1.943 million during the period, marking a substantial 118.1% increase compared to the prior corresponding period. However, the loss attributable to owners of the company widened to RMB 73.475 million, a 38.77% rise year-on-year, with a loss per share of RMB 1.21.

According to the company's announcement, the revenue growth was primarily driven by a RMB 20 million milestone payment received from Yunze Chuangyao in July 2025, alongside the group's continued fulfillment of its performance obligations under relevant research and development services during the reporting period. The payment is recognized as revenue over time based on the percentage of completion, calculated using the cost-input method—a ratio derived from actual costs incurred relative to the estimated total costs required to fully satisfy the group's contractual obligations. The unrecognized portion of the payment has been recorded as contract liabilities on the balance sheet.